SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-030937
Filing Date
2018-12-13
Accepted
2018-12-13 18:30:19
Documents
2
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1551
2 EX-24 DOCUMENT attachment1.htm EX-24 3753
  Complete submission text file 0000899243-18-030937.txt   6645
Mailing Address C/O AUXILIUM PHARMACEUTICALS, INC. 640 LEE ROAD CHESTERBROOK PA 19355
Business Address
ADAMS ADRIAN (Reporting) CIK: 0001248144 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36352 | Film No.: 181234202

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations